THOMPSON JOHN CRAIG bought ESPR
July 1, 2025 · Form 4 insider transaction
THOMPSON JOHN CRAIG bought 40,000 shares of Esperion Therapeutics, Inc. Common Stock at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
40,000
Price
$0.00
Total value
N/A
InsiderTHOMPSON JOHN CRAIG
Role—
SecurityStock Option (right to buy)
Transaction codeA: Grant or award
Transaction dateJuly 1, 2025
Filing dateJuly 2, 2025
Shares owned after40,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The awards vest over a three (3) year period in equal annual installments the first of which will be July 1, 2026.